American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

Clicks: 309
ID: 116044
1994
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
CSFs are recommended in some situations, eg, to reduce the likelihood of febrile neutropenia when the expected incidence is > or = 40%; after documented febrile neutropenia in a prior chemotherapy cycle to avoid infectious complications and maintain dose-intensity in subsequent treatment cycles w …
Reference Key
1994journalamerican Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;
Journal journal of clinical oncology : official journal of the american society of clinical oncology
Year 1994
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/7964965
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review clinical trials as topic humans pubmed abstract nih national institutes of health national library of medicine adult Child Comparative Study Medical* United States practice guideline guideline societies drug-related side effects and adverse reactions neoplasms / therapy pmid:7964965 doi:10.1200/jco.1994.12.11.2471 colony-stimulating factors / adverse effects colony-stimulating factors / economics colony-stimulating factors / therapeutic use* medical oncology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.